Prosecution Insights
Last updated: May 29, 2026
Application No. 18/850,689

TRIAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TRIAZOLE COMPOUND, COUPLING AGENT AND USES THEREOF

Non-Final OA §102§103
Filed
Sep 25, 2024
Priority
Mar 29, 2022 — JP 2022-054330 +1 more
Examiner
SHEWAREGED, BETELHEM
Art Unit
1785
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shikoku Chemicals Corporation
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
729 granted / 1017 resolved
+6.7% vs TC avg
Moderate +9% lift
Without
With
+8.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
35 currently pending
Career history
1055
Total Applications
across all art units

Statute-Specific Performance

§103
86.5%
+46.5% vs TC avg
§102
9.5%
-30.5% vs TC avg
§112
1.4%
-38.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1017 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I Claims 1-7 and 17 in the reply filed on 12/16/2025 is acknowledged. Claims 8-16 and 18-20 are currently withdrawn from consideration as non-elected invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1 and 2 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Oneil et al. (DE 3635636 A1). Claim 1: Oneil teaches a triazole compound represented by the following formula IV (page 5, line 25 of foreign patent DE3635636 A1). PNG media_image1.png 155 781 media_image1.png Greyscale Oneil teaches n is 2, 3 or 4 (see page 4 line 23-24 of the machine translation). The Chemical formula (I) reads on Formula IV of Oneil when R3 and R4 represent a hydrogen atom. Claim 2: The process by which the triazole compound is formed is not dispositive of the issue of the patentability of the instant product claim. Claims 3 and 17 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Oneil et al. (DE 3635636 A1). Claim 3: Oneil teaches a triazole compound represented by the following formula IV (page 5, line 25 of foreign patent DE3635636 A1). PNG media_image1.png 155 781 media_image1.png Greyscale Oneil teaches n is 2, 3 or 4 (see page 4 line 23-24 of the machine translation). The Chemical formula (I) reads on Formula IV of Oneil when R3 and R4 represent a hydrogen atom. Claim 17: Oneil teaches the triazole compound can be mixed or combined with additional such as polymethacrylate and sodium nitrate (see page 11, lines 19, 33 and 34 of machine translation). The polymethacrylate meets the claimed resin and the sodium nitrate meets the claimed inorganic material. Claims 4, 5 and 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Oneil et al. (DE 3635636 A1). Claim 4: Oneil teaches a triazole compound represented by the following formula IV (page 5, line 25 of foreign patent DE3635636 A1). PNG media_image1.png 155 781 media_image1.png Greyscale Oneil teaches n is 2, 3 or 4 (see page 4, line 23-24 of the machine translation). The Chemical formula (I) reads on Formula IV of Oneil when R3 and R4 represent a hydrogen atom. Claim 5: Oneil teaches the triazole compound can be applied to a copper substrate as a corrosion inhibitor (see page 5, lines 18-19 of the machine translation). Claim 7: Oneil teaches the triazole compound can be applied to a copper substrate as a corrosion inhibitor (see page 5, lines 18-19 of the machine translation). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 6 is rejected under 35 U.S.C. 103 as being unpatentable over Oneil et al. (DE 3635636 A1) as applied to claim 4, and further in view of Fukuda et. (US 2020/0123422 A1). Oneil teaches the claimed invention as set forth above. Claim 6: Oneil does not teach using the triazole based corrosion inhibitor with an adhesive agent. However, Fukuda teaches a triazole based corrosion inhibitor in adhesive agent composition [0102]. Oneil and Fukuda are analogous art because they are from the same field of endeavor that is the triazole based corrosion inhibitor. It would have been obvious to a person of ordinary skill in the art before the effective filing date of the invention to combine the adhesive agent of Fukuda with the invention of Oneil, and the motivation for combining would be to enhance the adhering property of the triazole based corrosion inhibitor. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to BETELHEM SHEWAREGED whose telephone number is (571)272-1529. The examiner can normally be reached Monday -Friday 7am-4:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Ruthkosky can be reached at 571-272-1291. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. BS February 6, 2026 /BETELHEM SHEWAREGED/ Primary Examiner Art Unit 1785
Read full office action

Prosecution Timeline

Sep 25, 2024
Application Filed
Feb 20, 2026
Non-Final Rejection mailed — §102, §103
May 06, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636855
PRE-APPLIED MEMBRANE WITH ANTI-SUBMARINING LAYER
4y 11m to grant Granted May 26, 2026
Patent 12636858
In-Mold Composite Surfacing Film
4y 3m to grant Granted May 26, 2026
Patent 12629934
Recording Method And Recording Device
3y 1m to grant Granted May 19, 2026
Patent 12624238
PRINTED MATERIAL
2y 11m to grant Granted May 12, 2026
Patent 12624181
FLUORINE-FREE HYDROPHOBIC PERMEABLE MATERIAL
2y 1m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
80%
With Interview (+8.7%)
2y 7m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1017 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month